[Tyrosine kinase inhibitors. An approach to pathogenesis-oriented tumor therapy]

Internist (Berl). 1997 Nov;38(11):1074-82. doi: 10.1007/s001080050120.

[Article in German]

Authors

F Alves¹, W Hiddemann

Affiliation

¹ Abteilung Hämatologie und Onkologie, Universitätsklinik Göttingen.

PMID: 9453957
DOI: 10.1007/s001080050120

No abstract available

Publication types

Review

MeSH terms

Animals
Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use*
Cell Division / drug effects
Cell Division / physiology
Humans
Neoplasms / drug therapy*
Neoplasms / physiopathology
Neovascularization, Pathologic / drug therapy
Neovascularization, Pathologic / physiopathology
Protein-Tyrosine Kinases / antagonists & inhibitors*
Protein-Tyrosine Kinases / physiology
Signal Transduction / drug effects
Signal Transduction / physiology
Treatment Outcome

Substances

Antineoplastic Agents
Protein-Tyrosine Kinases